Thomas Dahl

1.7k total citations
44 papers, 1.5k citations indexed

About

Thomas Dahl is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Thomas Dahl has authored 44 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 9 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in Thomas Dahl's work include bioluminescence and chemiluminescence research (5 papers), Photodynamic Therapy Research Studies (5 papers) and Heat shock proteins research (5 papers). Thomas Dahl is often cited by papers focused on bioluminescence and chemiluminescence research (5 papers), Photodynamic Therapy Research Studies (5 papers) and Heat shock proteins research (5 papers). Thomas Dahl collaborates with scholars based in United States, Australia and Netherlands. Thomas Dahl's co-authors include W. Robert Midden, Philip Hartman, Robert H. Sik, Ann G. Motten, Colin F. Chignell, Krzysztof J. Reszka, Mark A. Shand, Wendy J. Dixon, Margaret E. Daub and Stephen D. Gillies and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Thomas Dahl

40 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Dahl United States 16 417 341 293 255 247 44 1.5k
Jitender Madan India 29 828 2.0× 175 0.5× 214 0.7× 376 1.5× 207 0.8× 148 2.6k
Driton Vllasaliu United Kingdom 28 907 2.2× 256 0.8× 265 0.9× 448 1.8× 148 0.6× 63 2.6k
Kazuhiko Juni Japan 25 400 1.0× 187 0.5× 244 0.8× 211 0.8× 93 0.4× 104 2.0k
Dolores Torres Spain 29 1.0k 2.4× 177 0.5× 229 0.8× 345 1.4× 179 0.7× 62 2.9k
Weifen Zhang China 25 710 1.7× 376 1.1× 114 0.4× 460 1.8× 90 0.4× 71 2.2k
Christiane Damgé France 25 671 1.6× 160 0.5× 136 0.5× 186 0.7× 102 0.4× 55 2.3k
Kiran Sonaje Taiwan 18 824 2.0× 106 0.3× 150 0.5× 238 0.9× 265 1.1× 21 2.8k
Krishnan Rathinasamy India 23 754 1.8× 104 0.3× 317 1.1× 316 1.2× 321 1.3× 43 1.8k
Aijaz Ahmed Khan India 23 361 0.9× 78 0.2× 133 0.5× 307 1.2× 96 0.4× 79 1.8k

Countries citing papers authored by Thomas Dahl

Since Specialization
Citations

This map shows the geographic impact of Thomas Dahl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Dahl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Dahl more than expected).

Fields of papers citing papers by Thomas Dahl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Dahl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Dahl. The network helps show where Thomas Dahl may publish in the future.

Co-authorship network of co-authors of Thomas Dahl

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Dahl. A scholar is included among the top collaborators of Thomas Dahl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Dahl. Thomas Dahl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Verster, Joris C., et al.. (2021). Functional observation after morphine withdrawal: effects of SJP-005. Psychopharmacology. 238(6). 1449–1460. 5 indexed citations
4.
Dahl, Thomas, et al.. (2014). Kartlegging av kompetansemiljøenes arbeid med skolebasert kompetanseutvikling - høsten 2013. Duo Research Archive (University of Oslo). 1 indexed citations
5.
Dahl, Thomas, et al.. (2007). Kartlegging av utbredelse av leksehjelp i norsk skole. BIBSYS Brage (BIBSYS (Norway)). 1 indexed citations
6.
Desai, Apurva A., Mark J. Ratain, Mike Tipton, et al.. (2006). A phase 1, dose-escalation trial of STA-5312, a microtubule inhibitor with a novel binding site, in advanced or metastatic solid malignancies. Journal of Clinical Oncology. 24(18_suppl). 13040–13040. 2 indexed citations
7.
Weber, Robert, John D. Hainsworth, L. Schwartzberg, et al.. (2005). A phase 1/2 study of STA-4783 in combination with paclitaxel and carboplatin in chemo-naïve advanced non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 23(16_suppl). 7106–7106. 6 indexed citations
8.
Koya, Keizo, Lijun Sun, Shoujun Chen, et al.. (2004). Effects of the guanine-quadruplex telomerase inhibitor BRACO-19 on tumour cells: Evidence of selective action on telomere maintenance. Cancer Research. 64. 346–346. 1 indexed citations
9.
Ko, Yoo‐Joung, Glenn J. Bubley, Robert Weber, et al.. (2004). Safety, Pharmacokinetics, and Biological Pharmacodynamics of the Immunocytokine EMD 273066 (huKS-IL2). Journal of Immunotherapy. 27(3). 232–239. 52 indexed citations
10.
Berkenblit, Anna, et al.. (2004). STA-4783, a novel HSP inducer, enhances paclitaxel activity—Preclinical to clinical modeling. Journal of Clinical Oncology. 22(14_suppl). 3124–3124. 4 indexed citations
11.
Gewurz, Benjamin E., et al.. (2004). Capravirine, a Nonnucleoside Reverse‐Transcriptase Inhibitor in Patients Infected with HIV‐1: A Phase 1 Study. The Journal of Infectious Diseases. 190(11). 1957–1961. 12 indexed citations
12.
Dezube, Bruce J., Thomas Dahl, Naoto Yamaguchi, et al.. (2000). A Fusion Inhibitor (FP‐21399) for the Treatment of Human Immunodeficiency Virus Infection: A Phase I Study. The Journal of Infectious Diseases. 182(2). 607–610. 20 indexed citations
13.
Chignell, Colin F., et al.. (1994). SPECTRAL AND PHOTOCHEMICAL PROPERTIES OF CURCUMIN. Photochemistry and Photobiology. 59(3). 295–302. 365 indexed citations
14.
Camoirano, Anna, Silvio De Flora, & Thomas Dahl. (1993). Genotoxicity of volatile and secondary reactive oxygen species generated by photosensitization. Environmental and Molecular Mutagenesis. 21(3). 219–228. 15 indexed citations
15.
Midden, W. Robert & Thomas Dahl. (1992). Biological inactivation by single oxygen: distinguishing O2(1Δg) and O2(1Σg+). Biochimica et Biophysica Acta (BBA) - General Subjects. 1117(2). 216–222. 10 indexed citations
16.
Dahl, Thomas, et al.. (1989). Photokilling of bacteria by the natural dye curcumin. Archives of Microbiology. 151(2). 183–185. 139 indexed citations
17.
Dahl, Thomas, Oscar Valdes‐Aguilera, W. Robert Midden, & D. C. Neckers. (1989). Partition of rose bengal anion from aqueous medium into a lipophilic environment in the cell envelope of Salmonella typhimurium: Implications for cell-type targeting in photodynamic therapy. Journal of Photochemistry and Photobiology B Biology. 4(2). 171–184. 27 indexed citations
18.
Midden, W. Robert, Thomas Dahl, & Philip Hartman. (1988). Cytotoxicity But No Mutagenicity In Bacteria With Externally Generated Singlet Oxygen. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 847. 122–122. 4 indexed citations
19.
Dahl, Thomas, W. Robert Midden, & Philip Hartman. (1988). SOME PREVALENT BIOMOLECULES AS DEFENSES AGAINST SINGLET OXYGEN DAMAGE. Photochemistry and Photobiology. 47(3). 357–362. 148 indexed citations
20.
Dahl, Thomas, Christina Moberg, Christian Pedersen, et al.. (1973). (Trichloromethyl)cyclopentadiene from pi-Cyclopentadienyl[(trichloromethyl)cyclopentadiene]cobalt.. Acta chemica Scandinavica/Acta chemica Scandinavica. B, Organic chemistry and biochemistry/Acta chemica Scandinavica. A, Physical and inorganic chemistry/Acta chemica Scandinavica. Series B. Organic chemistry and biochemistry/Acta chemica Scandinavica. Series A, Physical and inorganic chemistry. 27. 728–728. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026